This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Elan Pharmaceuticals, Inc., Wyeth. Active years: 2006-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2006-2008
Title: Brian P. Stupi: Innovator in Inflammatory Disease Treatment
Introduction
Brian P. Stupi is a notable inventor based in Moss Beach, CA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target inflammatory diseases. With a total of 4 patents, his work has the potential to impact the treatment of various serious health conditions.
Latest Patents
Stupi's latest patents focus on compounds that bind to α-integrins, specifically VLA-4. These compounds are designed to inhibit leukocyte adhesion, which is crucial in the treatment of inflammatory diseases. The applications of these compounds extend to conditions such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis, and myocardial ischemia. Additionally, they can be utilized for treating inflammatory brain diseases like multiple sclerosis.
Career Highlights
Throughout his career, Brian P. Stupi has worked with prominent companies in the pharmaceutical industry, including Elan Pharmaceuticals, Inc. and Wyeth. His experience in these organizations has contributed to his expertise in developing innovative treatments for complex diseases.
Collaborations
Stupi has collaborated with notable professionals in his field, including Andrei William Konradi and Christopher Michael Semko. These partnerships have likely enhanced his research and development efforts.
Conclusion
Brian P. Stupi's work in developing compounds for the treatment of inflammatory diseases showcases his innovative spirit and dedication to improving patient outcomes. His contributions to medicinal chemistry are significant and continue to influence the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile